The prognostic role of 1q21 gain/amp in newly diagnosed multiple myeloma: the faster, the worse

被引：0
|
作者：
Wang, Yawen [1 ]
Xu, Jiadai [1 ]
Liu, Peng [1 ]
Li, Panpan [1 ]
机构：
[1] Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2022年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-227
引用
收藏
页码：S160 / S160
页数：1
相关论文
共 50 条
  • [21] Gain/Amplification of Chromosome Arm 1q21 in Multiple Myeloma
    Hanamura, Ichiro
    CANCERS, 2021, 13 (02) : 1 - 16
  • [22] The paradoxical prognostic role of 1q21 Gain/Amplification in multiple myeloma: every coin has two sides
    Xu, Jiadai
    Xu, Tianhong
    Yang, Yang
    Wang, Wenjing
    Li, Jing
    Ren, Yuhong
    Gu, Shiyang
    Chen, Chen
    Wei, Zheng
    Zhuang, Jingli
    Wang, Zhimei
    Ji, Lili
    Cheng, Luya
    Wang, Weiguang
    Cheng, Zhixiang
    Ke, Yang
    Yuan, Ling
    Liu, Peng
    LEUKEMIA & LYMPHOMA, 2020, 61 (10) : 2351 - 2364
  • [23] Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma
    Weinhold, Niels
    Kirn, Desiree
    Seckinger, Anja
    Hielscher, Thomas
    Granzow, Martin
    Bertsch, Uta
    Egerer, Gerlinde
    Salwender, Hans
    Blau, Igor W.
    Weisel, Katja
    Hillengass, Jens
    Raab, Marc S.
    Hose, Dirk
    Goldschmidt, Hartmut
    Jauch, Anna
    HAEMATOLOGICA, 2016, 101 (03) : E116 - E119
  • [24] PROGNOSTIC SIGNIFICANCE OF AMP1Q21 IN MULTIPLE MYELOMA
    Abramova, T.
    Obukhova, T.
    Mendeleeva, L.
    Pokrovskaya, O.
    Gribanova, E.
    Nareyko, M.
    Grebenyuk, L.
    Votyakova, O.
    Solovev, M.
    Firsova, M.
    Nakastoev, I.
    Grachev, A.
    Kanaeva, M.
    Danilina, A.
    Kulikov, S.
    Rusinov, M.
    Savchenko, V.
    HAEMATOLOGICA, 2017, 102 : 503 - 503
  • [25] Chromosome 1q21 abnormalities in multiple myeloma
    Schmidt, Timothy M.
    Fonseca, Rafael
    Usmani, Saad Z.
    BLOOD CANCER JOURNAL, 2021, 11 (04)
  • [26] Effect of amplification or gain of 1Q21 in patients with multiple myeloma treated with daratumumab
    Zamanillo, Irene
    Medina de Alba, Lucia
    Alonso, Rafael
    Maria Sanchez, Jose
    Cuellar, Clara
    Fernandez-Guijarro, Manuela
    Martinez-Lopez, Joaquin
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S235 - S236
  • [27] Chromosome 1q21 abnormalities in multiple myeloma
    Timothy M. Schmidt
    Rafael Fonseca
    Saad Z. Usmani
    Blood Cancer Journal, 11
  • [28] The impact of Bortezomib-based induction on chromosome 1q21 gained newly diagnosed Multiple Myeloma of Chinese origin
    Tang, Hoi Ki Karen
    Fung, Chi Yeung
    Morgan, Gareth
    Siu, Lisa
    Ip, Ho Wan Alvin
    Yip, Sze Fai
    Lau, Ka Ngai Harry
    Wong, Howard
    Kho, Bonnie
    Lee, Harold
    Leung, Kwan Hung
    Lau, Chi Kuen
    Chim, Chor Sang
    Hwang, Yu Yan
    Sim, Joycelyn
    Ngai, Cheong
    Kwong, Yok Lam
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S72 - S73
  • [29] THE AMPLIFICATION OF 1Q21 IS AN ADVERSE PROGNOSTIC FACTOR IN CHINESE PATIENTS WITH MULTIPLE MYELOMA
    Chen, L.
    Yu, W.
    Zhang, R.
    Qu, X.
    Qiu, H.
    Guo, R.
    Li, J.
    HAEMATOLOGICA, 2015, 100 : 519 - 519
  • [30] Impact of Gain 1q21 (1q21+) in Patients with multiple Myeloma and Translocation t(11;14)
    Udovica, S.
    Scherbler, W.
    Fritz, P.
    Schneller, A.
    Ludwig, H.
    Zojer, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 144 - 144
12345